Specialty care.

Advances in immunohistochemistry has opened the door to Mohs micrographic surgery as a less morbid treatment option for T1-2a melanoma, though this NCDB analysis warns survival may be compromised if performed at a low-volume and/or non-academically-affiliated practice. | Cheraghlou, JAMA Dermatol 2021

Comments

Popular Posts